Index Fund Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$973K Sell
1,058
-194
-15% -$197K 0.04% 66
2025
Q4
$1.35M Buy
1,252
+7
+0.6% +$6.69K 0.06% 57
2025
Q3
$950K Buy
1,245
+27
+2% +$20.1K 0.05% 64
2025
Q2
$950K Buy
1,218
+749
+160% +$582K 0.05% 58
2025
Q1
$387K Sell
469
-176
-27% -$146K 0.02% 59
2024
Q4
$498K Sell
645
-45
-7% -$37.3K 0.03% 63
2024
Q3
$611K Sell
690
-27
-4% -$24.3K 0.03% 54
2024
Q2
$649K Buy
717
+60
+9% +$48K 0.04% 49
2024
Q1
$511K Buy
657
+21
+3% +$14.9K 0.03% 56
2023
Q4
$371K Sell
636
-82
-11% -$47.9K 0.02% 63
2023
Q3
$385K Sell
718
-10
-1% -$5.15K 0.03% 64
2023
Q2
$341K Buy
728
+91
+14% +$38.2K 0.02% 69
2023
Q1
$219K Sell
637
-5
-0.8% -$1.69K 0.01% 85
2022
Q4
$235K Sell
642
-394
-38% -$140K 0.02% 74
2022
Q3
$335K Buy
1,036
+1
+0.1% +$317 0.03% 65
2022
Q2
$336K Buy
+1,035
New +$311K 0.03% 65

Other funds holding LLY

Index Fund Advisors's LLY Position: Q1 2026 in Review

Index Fund Advisors reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $197K and leaving 1,058 shares worth $973K. The position accounts for 0.04% of the portfolio, ranked #66.

Index Fund Advisors first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.35M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Index Fund Advisors held 1,058 shares of Eli Lilly worth $973K as of Q1 2026.
  • Index Fund Advisors sold 194 Eli Lilly shares in Q1 2026, an estimated $197K.
  • Eli Lilly made up 0.04% of Index Fund Advisors's portfolio in Q1 2026, its #66 holding.
  • Index Fund Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Index Fund Advisors's Eli Lilly position peaked at $1.35M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Index Fund Advisors's 13F filing for Q1 2026, filed 12 May 2026.